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Cells communicate with other cells not only via direct cell–cell contact and the
production of signaling molecules but also through release of microparticles (MPs).
MPs are small vesicles released from stimulated and/or apoptotic cells. They
harbor membrane proteins that are characteristic of the original parent cell and
intracellular components involved in cell signaling. MPs are considered to be both
biomarkers and effectors of cell signaling that maintain and/or initiate cell
dysfunction. Thus, MPs can evoke endothelial dysfunction by decreasing nitric
oxide (NO) production and promoting vascular inflammation which favor the
prothrombotic state in atherosclerosis. Novel pharmacological approaches
targeting MP production or properties could be used to treat cardiovascular
pathologies. Paradoxically, another useful approach might be to employ engineered
MPs with modified compositions as therapeutic agents to correct cardiovascular
pathologies. This review is focused on the mechanisms of MP formation and their
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